Cargando…

Innovative CRISPR Screening Promotes Drug Target Identification

Detalles Bibliográficos
Autores principales:	Ling, Xinyu, Liu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686203/ https://www.ncbi.nlm.nih.gov/pubmed/36439304 http://dx.doi.org/10.1021/acscentsci.2c01142

Ejemplares similares

Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
por: Deans, Richard M., et al.
Publicado: (2016)

Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
por: Shi, Junwei, et al.
Publicado: (2015)

Identification of Intrinsic Drug Resistance and Its Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens
por: Ayestaran, Iñigo, et al.
Publicado: (2020)

CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
por: Szlachta, Karol, et al.
Publicado: (2018)

Identification of NRAS Downstream Genes with CRISPR Activation Screening
por: Tatsumi, Akiya, et al.
Publicado: (2022)

To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases
por: Onishi, Iichiroh, et al.
Publicado: (2021)

Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
por: Hendriks, Delilah, et al.
Publicado: (2023)

CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer
por: Gao, Shanshan, et al.
Publicado: (2021)

DSCN: Double-target selection guided by CRISPR screening and network
por: Liu, Enze, et al.
Publicado: (2022)

Computational identification of clonal cells in single-cell CRISPR screens
por: Wang, Yihan, et al.
Publicado: (2022)

Identifying chemogenetic interactions from CRISPR screens with drugZ
por: Colic, Medina, et al.
Publicado: (2019)

A Flexible, Pooled CRISPR Library for Drug Development Screens
por: Blanck, Maximilian, et al.
Publicado: (2020)

Genome-scale CRISPR screening for potential targets of ginsenoside compound K
por: Yang, Yuanyuan, et al.
Publicado: (2020)

Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening
por: Hou, Jue, et al.
Publicado: (2022)

Identification of cell type specific ACE2 modifiers by CRISPR screening
por: Sherman, Emily J., et al.
Publicado: (2022)

An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML
por: Lin, Shan, et al.
Publicado: (2022)

Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens
por: Yim, Soorin, et al.
Publicado: (2022)

CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets
por: Noorani, Imran, et al.
Publicado: (2020)

CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer
por: Tsujino, Takuya, et al.
Publicado: (2021)

Efficient generation of locus-specific human CAR-T cells with CRISPR/cCas12a
por: Ling, Xinyu, et al.
Publicado: (2022)

Methodology of drug screening and target identification for new necroptosis inhibitors
por: Pan, Pengchao, et al.
Publicado: (2019)

A large-scale CRISPR screen and identification of essential genes in cellular senescence bypass
por: Liu, Xuehui, et al.
Publicado: (2019)

Drug mechanism‐of‐action discovery through the integration of pharmacological and CRISPR screens
por: Gonçalves, Emanuel, et al.
Publicado: (2020)

Identification of Autophagy-Related Genes as Targets for Senescence Induction Using a Customizable CRISPR-Based Suicide Switch Screen
por: Schepers, Arnout, et al.
Publicado: (2021)

Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology
por: Yuan, Ning-Ning, et al.
Publicado: (2019)

Systematic identification of CRISPR off-target effects by CROss-seq
por: Li, Yan, et al.
Publicado: (2022)

Bioinformatics approaches to analyzing CRISPR screen data: from dropout screens to single-cell CRISPR screens
por: Zhao, Yueshan, et al.
Publicado: (2022)

Identification of functional regulatory elements in the human genome using pooled CRISPR screens
por: Borys, Samantha M., et al.
Publicado: (2020)

CRISPR screens identify gene targets at breast cancer risk loci
por: Tuano, Natasha K., et al.
Publicado: (2023)

Bioinformatics Identification of Anti-CRISPR Loci by Using Homology, Guilt-by-Association, and CRISPR Self-Targeting Spacer Approaches
por: Yin, Yanbin, et al.
Publicado: (2019)

CRISPR screening in cardiovascular research
por: Shan, Haihuan, et al.
Publicado: (2023)

Innovative Approach for a Classic Target: Fragment Screening on Trypanothione Reductase Reveals New Opportunities for Drug Design
por: Fiorillo, Annarita, et al.
Publicado: (2022)

Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation
por: Salvati, Anna, et al.
Publicado: (2022)

CRISPR-FOCUS: A web server for designing focused CRISPR screening experiments
por: Cao, Qingyi, et al.
Publicado: (2017)

Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2
por: Kim, Garam, et al.
Publicado: (2022)

Efficient Identification of the MYC Regulator with the Use of the CRISPR Library and Context-Matched Database Screenings
por: Tanaka, Yosuke, et al.
Publicado: (2022)

Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening
por: Kiessling, Michael K., et al.
Publicado: (2016)

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
por: Griffin, Matthew D., et al.
Publicado: (2020)

Efficient prioritization of CRISPR screen hits by accounting for targeting efficiency of guide RNA
por: Park, Byung-Sun, et al.
Publicado: (2023)

acCRISPR: an activity-correction method for improving the accuracy of CRISPR screens
por: Ramesh, Adithya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sgk0kig9mlo8m4us3mri5o7rke